ArticleTranslational lung cancer research2025

Investigation of non-completion factors for durvalumab maintenance therapy in locally advanced non-small cell lung cancer.

Masaaki Kotake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.